Emibetuzumab, CAS 1365287-97-3

Product Description: Emibetuzumab (LY2875358) is a humanized bivalent MET antibody (IgG4 type). Emibetuzumab shows high neutralization and internalization activities, resulting in inhibition of both HGF-dependent and HGF-independent MET pathway activation and tumor growth. Emibetuzumab can be used in study of cancer[1].

Applications: Cancer-Kinase/protease

Formula: N/A

References: [1]Liu L, et al. LY2875358, a neutralizing and internalizing anti-MET bivalent antibody, inhibits HGF-dependent and HGF-independent MET activation and tumor growth. Clin Cancer Res. 2014 Dec 1;20(23):6059-70.

CAS Number: 1365287-97-3

Molecular Weight: N/A

Compound Purity: 95.00

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: c-Met/HGFR

• Artikelnummer: MEXHY-P99192-10
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99192-10
• Green Labware: Nein
• Verpackungseinheit: 10 mg
• Mengeneinheit: STK